your market intelligence analyst
Search Results
Edit Save
212,919 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
π‐Extended systems are key components for the development of future organic electronic technologies. While conceiving molecules with improved properties is fundamental for the evolution of materials science, keeping control over the 3D arrangement of molecules represents an ever‐expanding challenge. Herein, a synthetic protocol to replace carbon atoms of π‐systems by dissymmetric phosphorus atoms is reported; in particular, it allowed for conceiving new fused phosphapyrene derivatives with improved properties. The presence of dissymmetric phosphorus atoms precluded the formation of excimers. X‐ray diffraction revealed that, meanwhile, strong intermolecular interactions are taking place in the solid state. The phosphapyrenes photoluminesce i.
Business Wire 09/28/2020 08:30
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) announced today its lineup of abstract presentations at the AABB 2020 Virtual Annual Meeting, which will take place on October 3rd through October 5th. This year’s Virtual Annual Meeting remains one of the largest scientific symposiums focused on the field of transfusion medicine. Scientists and clinicians from around the globe will share the latest research and practice-changing resources in the fields of blood and biotherapies.
Business Wire 09/28/2020 08:30
HOUSTON--(BUSINESS WIRE)--Orion Group Holdings, Inc. (NYSE: ORN) (“Orion” or “the Company”) a leading specialty construction company, today announced a contract award of approximately $16 million. The Company’s Marine segment has been awarded a competitively bid contract from the US Army Corps of Engineers to provide dredging services in Galveston, Texas. The project calls for the dredging and removal of approximately 5 million cubic yards of maintenance material from the inner Galveston Harbor.
Business Wire 09/28/2020 08:30
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that the Fourth Intermediate People’s Court of Beijing ("Beijing Fourth Court") issued a judgement holding Sinobioway Bio-medicine Co., Ltd. ("Sinobioway Medicine") and Mr. Aihua Pan (collectively, "the Defendants") liable for torts and breaches of shareholder fiduciary duty.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios